Home Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

FPG #8: Alternative Treatments in Psychiatry
FPG #7: Critical Care in Neurology
Free Medical Books

  Ovarian Neoplasms

  Free Subscription


16.01.2012

1 Ann Oncol
2 Br J Cancer
1 Cancer
1 Cancer Chemother Pharmacol
1 Cancer Res
2 Gynecol Oncol
1 Int J Oncol
1 J Natl Cancer Inst


   Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Ann Oncol

  1. BONDONG S , Kiefel H, Hielscher T, Zeimet AG, et al
    Prognostic significance of L1CAM in ovarian cancer and its role in constitutive NF-kappaB activation.
    Ann Oncol. 2012.
    PubMed     Text format     Related articles    Abstract available



    Br J Cancer

  2. COLEY HM , Safuwan NA, Chivers P, Papacharalbous E, et al
    The cyclin-dependent kinase inhibitor p57(Kip2) is epigenetically regulated in carboplatin resistance and results in collateral sensitivity to the CDK inhibitor seliciclib in ovarian cancer.
    Br J Cancer. 2012 Jan 10. doi: 10.1038/bjc.2011.
    PubMed     Text format     Related articles    Abstract available


  3. BLANK MM , Wentzensen N, Murphy MA, Hollenbeck A, et al
    Dietary fat intake and risk of ovarian cancer in the NIH-AARP Diet and Health Study.
    Br J Cancer. 2012 Jan 5. doi: 10.1038/bjc.2011.
    PubMed     Text format     Related articles    Abstract available



    Cancer

  4. TRIVERS KF , Baldwin LM, Miller JW, Matthews B, et al
    Reported referral for genetic counseling or BRCA 1/2 testing among United States physicians: a vignette-based study.
    Cancer. 2011;117:5334-43.
    PubMed     Text format     Related articles    Abstract available



    Cancer Chemother Pharmacol

  5. BJORKLUND M , Roos J, Gogvadze V, Shoshan M, et al
    Resveratrol induces SIRT1- and energy-stress-independent inhibition of tumor cell regrowth after low-dose platinum treatment.
    Cancer Chemother Pharmacol. 2011;68:1459-67.
    PubMed     Text format     Related articles    Abstract available



    Cancer Res

  6. GUAN B , Wang TL, Shih IM
    ARID1A, a factor that promotes formation of SWI/SNF-mediated chromatin remodeling, is a tumor suppressor in gynecologic cancers.
    Cancer Res. 2011.
    PubMed     Text format     Related articles    Abstract available



    Gynecol Oncol

  7. ANSALONI L , De Iaco P, Frigerio L
    Re: "Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy as upfront therapy for advanced epithelial ovarian cancer: Multi-institutional phase-II trial." - Proposal of a clinical trial of cytoreductive surgery and hyperthermic intraperi
    Gynecol Oncol. 2012.
    PubMed     Text format     Related articles   


  8. THRALL MM , Gray HJ, Goff BA
    Letter-to-the Editor "Trends in treatment of advanced epithelial ovarian cancer in the Medicare population"
    Gynecol Oncol. 2012.
    PubMed     Text format     Related articles   



    Int J Oncol

  9. MARTINEZ-POVEDA B , Gomez V, Alcaide-German M, Perruca S, et al
    Non-invasive monitoring of hypoxia-inducible factor activation by optical imaging during antiangiogenic treatment in a xenograft model of ovarian carcinoma.
    Int J Oncol. 2011 Jun 9. doi: 10.3892/ijo.2011.1074.
    PubMed     Text format     Related articles    Abstract available



    J Natl Cancer Inst

  10. ANDRIOLE GL , Crawford ED, Grubb RL 3rd, Buys SS, et al
    Prostate Cancer Screening in the Randomized Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial: Mortality Results after 13 Years of Follow-up.
    J Natl Cancer Inst. 2012.
    PubMed     Text format     Related articles    Abstract available



Thank you for your interest in scientific medicine.


Amedeo is a Flying Publisher website.

   Design: